These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38844131)

  • 1. Mechanistic insights into complement pathway inhibition by CR1 domain duplication.
    Wymann S; Nair AG; Ewert S; Powers GA; Wan SS; Pelzing M; Baz Morelli A; Rowe T; Hardy MP
    J Biol Chem; 2024 Jul; 300(7):107451. PubMed ID: 38844131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.
    Klickstein LB; Bartow TJ; Miletic V; Rabson LD; Smith JA; Fearon DT
    J Exp Med; 1988 Nov; 168(5):1699-717. PubMed ID: 2972794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivo.
    Wymann S; Mischnik M; Leong D; Ghosh S; Tan X; Cao H; Kuehnemuth B; Powers GA; Halder P; de Souza MJ; James HS; Tomasetig V; Lind H; Rossato P; Owczarek CM; Ow SY; Dower SK; Baz Morelli A; Rowe T; Hardy MP
    Biochem J; 2022 May; 479(9):1007-1030. PubMed ID: 35470373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposed structure of the F' allotype of human CR1. Loss of a C3b binding site may be associated with altered function.
    Wong WW; Farrell SA
    J Immunol; 1991 Jan; 146(2):656-62. PubMed ID: 1670949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of C4b dimer binding to distinct sites on the C3b/C4b receptor (CR1).
    Reilly BD; Makrides SC; Ford PJ; Marsh HC; Mold C
    J Biol Chem; 1994 Mar; 269(10):7696-701. PubMed ID: 8125996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Molecular Mechanisms of Complement Receptor 1-It Is Complicated.
    Hardy MP; Mansour M; Rowe T; Wymann S
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway.
    Scesney SM; Makrides SC; Gosselin ML; Ford PJ; Andrews BM; Hayman EG; Marsh HC
    Eur J Immunol; 1996 Aug; 26(8):1729-35. PubMed ID: 8765013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships within the N-terminal short consensus repeats (SCR) of human CR1 (C3b/C4b receptor, CD35): SCR 3 plays a critical role in inhibition of the classical and alternative pathways of complement activation.
    Mossakowska D; Dodd I; Pindar W; Smith RA
    Eur J Immunol; 1999 Jun; 29(6):1955-65. PubMed ID: 10382758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution of two amino acids confers C3b binding to the C4b binding site of CR1 (CD35). Analysis based on ligand binding by chimpanzee erythrocyte complement receptor.
    Subramanian VB; Clemenza L; Krych M; Atkinson JP
    J Immunol; 1996 Aug; 157(3):1242-7. PubMed ID: 8757632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel soluble complement receptor 1 fragment with enhanced therapeutic potential.
    Wymann S; Dai Y; Nair AG; Cao H; Powers GA; Schnell A; Martin-Roussety G; Leong D; Simmonds J; Lieu KG; de Souza MJ; Mischnik M; Taylor S; Ow SY; Spycher M; Butcher RE; Pearse M; Zuercher AW; Baz Morelli A; Panousis C; Wilson MJ; Rowe T; Hardy MP
    J Biol Chem; 2021; 296():100200. PubMed ID: 33334893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-function relationships of complement receptor type 1.
    Krych-Goldberg M; Atkinson JP
    Immunol Rev; 2001 Apr; 180():112-22. PubMed ID: 11414353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using mutagenesis and structural biology to map the binding site for the Plasmodium falciparum merozoite protein PfRh4 on the human immune adherence receptor.
    Park HJ; Guariento M; Maciejewski M; Hauhart R; Tham WH; Cowman AF; Schmidt CQ; Mertens HD; Liszewski MK; Hourcade DE; Barlow PN; Atkinson JP
    J Biol Chem; 2014 Jan; 289(1):450-63. PubMed ID: 24214979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases.
    Pangburn MK
    J Immunol; 1986 Mar; 136(6):2216-21. PubMed ID: 2419425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins.
    Klickstein LB; Wong WW; Smith JA; Weis JH; Wilson JG; Fearon DT
    J Exp Med; 1987 Apr; 165(4):1095-112. PubMed ID: 2951479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1.
    Medof ME; Nussenzweig V
    J Exp Med; 1984 Jun; 159(6):1669-85. PubMed ID: 6233387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of C3b and C4b by the CR1-like site in murine CR1.
    Kalli KR; Fearon DT
    J Immunol; 1994 Mar; 152(6):2899-903. PubMed ID: 8144890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF).
    Seya T; Holers VM; Atkinson JP
    J Immunol; 1985 Oct; 135(4):2661-7. PubMed ID: 3161944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
    Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
    J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitor.
    Kalli KR; Hsu PH; Bartow TJ; Ahearn JM; Matsumoto AK; Klickstein LB; Fearon DT
    J Exp Med; 1991 Dec; 174(6):1451-60. PubMed ID: 1836011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface expression of the C3b/C4b receptor (CR1) protects Chinese hamster ovary cells from lysis by human complement.
    Makrides SC; Scesney SM; Ford PJ; Evans KS; Carson GR; Marsh HC
    J Biol Chem; 1992 Dec; 267(34):24754-61. PubMed ID: 1447213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.